Showing results (1641-1650 of 1,995) with videos related to

Sort By:
Pageof 200
Journal of Cardiovascular Pharmacology|July 1, 1983
Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitorE J Sybertz, T Baum, H S Ahn, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 27, 2017
Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-RJulinda Mehilli, Stephan Achenbach, Jochen Woehrle, et al.
Journal of the American Chemical Society|March 7, 2022
Probing the Mechanism of Isonitrile Formation by a Non-Heme Iron(II)-Dependent Oxidase/DecarboxylaseAntonio Del Rio Flores, David W Kastner, Yongle Du, et al.
BMC Proceedings|December 19, 2009
Data for Genetic Analysis Workshop 16 Problem 1, association analysis of rheumatoid arthritis dataChristopher I Amos, Wei Vivien Chen, Michael F Seldin, et al.
Nature Communications|November 28, 2024
Mechanistic basis for the emergence of EPS1 as a catalyst in salicylic acid biosynthesis of BrassicaceaeMichael P Torrens-Spence, Jason O Matos, Tianjie Li, et al.
Molecular Cancer Therapeutics|January 9, 2025
Inhibition of DKK-1 by WAY262611 Inhibits Osteosarcoma MetastasisAdit Tal, Shimara Gunawardana-Zeigler, Da Peng, et al.
Investigative Ophthalmology & Visual Science|April 20, 2026
Hyporeflective Core Drusen Cause an Artifactual Bending of Bruch's Membrane on OCT Images: Optical Mechanism and Proposed Quantitative MetricsViet-Hoan Le, Omar S El-Mulki, Yi Zhang, et al.
Asian Journal of Andrology|March 1, 2016
Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measuresKaran Wadhwa, Lina Carmona-Echeveria, Timur Kuru, et al.
Pageof 200